A unique MANNITOL powder formula containing 10% Mucuna powder.
 
Mannitol is a natural supplement targeting degenerative diseases of the central nervous system. It has been identified as a contributing factor to Parkinson's disease symptoms. Additionally, it serves as an alternative natural sweetener to sugar. Mannitol, acting as a sugar substitute in various food products, caters to individuals with diabetes or those adopting a health-conscious lifestyle aiming to reduce processed sugar consumption.
 
Mannitol benefits:
Some potential benefits of mannitol in the context of Parkinson's disease include:
Blood-Brain Barrier Permeability: Mannitol has been used in medical settings to temporarily open the blood-brain barrier, a protective barrier that regulates the passage of substances between the bloodstream and the brain. This temporary opening can facilitate the delivery of therapeutic agents, such as medications or stem cells, to the brain, which may be beneficial for treating Parkinson's disease.
Enhanced Drug Delivery: By temporarily opening the blood-brain barrier, mannitol can improve the delivery of medications to the brain, potentially enhancing their effectiveness in managing Parkinson's symptoms.
Reduced Brain Edema: Mannitol has osmotic properties, meaning it can draw water out of cells and reduce brain edema (swelling). In cases where brain edema is a concern in Parkinson's disease, mannitol may be used to help alleviate this symptom.

Mucuna benefits:
Mucuna, also known as velvet bean, has gained attention for its potential benefits in managing Parkinson's disease. Some of the potential benefits of Mucuna for Parkinson's disease include:
Source of natural L-Dopa: Mucuna contains high levels of L-Dopa, a precursor to dopamine. Dopamine deficiency is a key factor in Parkinson's disease, and L-Dopa supplementation can help alleviate symptoms by increasing dopamine levels in the brain.
Reduced Side Effects: Some research suggests that Mucuna may have fewer side effects compared to synthetic L-Dopa medications commonly used to treat Parkinson's disease. This could include a reduction in dyskinesia (involuntary movements) and other adverse effects associated with long-term use of synthetic L-Dopa.
Potential Neuroprotective Effects: Mucuna contains various antioxidants and neuroprotective compounds that may help protect brain cells from damage and slow the progression of Parkinson's disease.
Improved Symptom Management: Studies have shown that Mucuna supplementation can lead to improvements in motor symptoms, such as tremors, rigidity, and bradykinesia (slowness of movement), in individuals with Parkinson's disease.
Enhanced Quality of Life: By effectively managing symptoms and potentially reducing side effects, Mucuna supplementation may improve the overall quality of life for individuals living with Parkinson's disease.

Mannitol, in combination with Mucuna, can decrease the production of the alpha-synuclein protein and also support the increase in the amount of dopamine essential to healthy brain function.
 
Mannitol is a common low-calorie sweetener approved by the FDA and EFSA.